Directory Category: Drug Discovery

Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic

CLEVELAND, US – 21 June 2023 – The Lubrizol Corporation announces
the licensing of its novel excipient polymer technology, Apisolex
excipient, to Welton Pharma (Welton). The license allows Welton to use
the Apisolex excipient worldwide to develop and commercialise a novel
formulation of SN-38 to treat colorectal and associated
gastro-intestinal cancers.

Read More

Vetter Again Demonstrates Industry Leadership in Sustainability Initiatives

Ravensburg, Germany – 14 June 2023 – B3C newswire – Vetter, one
of the world’s leading Contract Development and Manufacturing
Organizations (CDMO), is consistently pursuing improvements to its
sustainability strategy. The globally-operating company released its
second-annual sustainability report. For the first time, the
pharmaceutical service provider headquartered in Ravensburg, Germany,
also reports its Scope 3 emissions and shows its CO2 balance according
to the requirements of the international Greenhouse Gas Protocol.

Read More